Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Cepheid, Biotage

Premium

This week, PerkinElmer launched its BioXpression biomarker platform, which "can speed the discovery of biomarkers" through its biomarker sample-enrichment technology and "highly accurate" mass pattern recognition approach, the company said this week in a statement. The BioXpression platform uses the company's proteomic signature technology that "delivers high throughput and ultra-high mass accuracy and stability, resulting in comprehensive and high-confidence" proteomic signatures, the company said


Cepheid this week introduced its Customer Specified Reagents program, which uses the company's SmartBead technology — customer-developed reagents are processed at by Cepheid using its bead technology, the company said in a statement this week. Customer Specified Reagents in the SmartBead format "provide customers with standardized reagents demonstrating enhanced stability, improved reproducibility, and greater efficiency," the company said.


Biotage last week launched its PyroMark Oncology Series genetic tests for genotyping specific cancer mutations and epigenetic phenomena, the company said last week in a statement. The four new tests analyze mutations in the KRAS gene, which is implicated in sporadic colorectal, pancreatic and lung cancers, and the BRAF gene, which is associated with malignant melanoma, papillary thyroid cancer and lung cancer, Biotage said. Additionally, the product quantifies the methylation status of the genes MLH1 and p16, which are hypermethylated in many tumors.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.